Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis

Lingxiao Chen,Zhenyu Ou,Ruizhe Wang,Mengda Zhang,Wei He,Junjie Zhang,Xiongbing Zu,Lu Yi,Ran Xu,Shusuan Jiang,Lin Qi,Long Wang

Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis

2019

Lingxiao Chen
Zhenyu Ou
Ruizhe Wang
Mengda Zhang
Wei He
Junjie Zhang
Xiongbing Zu
Lu Yi
Ran Xu
Shusuan Jiang
Lin Qi
Long Wang

Background To evaluate the benefit of neoadjuvant chemotherapy (NAC) for survival in high-grade upper tract urothelial carcinoma (UTUC), a propensity score-based analysis was performed with high-grade UTUC patients from multiple urologic centers.

Keywords:

Medicine
Surgical oncology
General surgery
Chemotherapy
Oncology
Propensity score matching
Internal medicine
Carcinoma
Hazard ratio
Hydronephrosis
Multivariate analysis
Lower risk
Confidence interval
Urology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations